Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Claritas Pharmaceuticals Inc V.CLAS.H

Alternate Symbol(s):  CLAZF

Claritas Pharmaceuticals, Inc., formerly Kalytera Therapeutics Inc, is a biotechnology company that is focused on developing R-107 for the treatment of vaccine-resistant coronavirus disease (COVID) strains. The Company’s products in development include R-107 for coronavirus disease and Viral Infections, R-107 and Vaccines, and CLA-1816 for treatment of pain. R-107 is designed to defeat COVID viruses on contact. R-107 targets the Achilles heel of COVID, the spike protein on the surface of the virus. R-107 releases nitric oxide, which attaches to a specific amino acid on the spike protein, thereby disabling the spike protein. The CLA-1816 provides effective pain reduction, without the risks of addiction or respiratory suppression that exist with opioid analgesics. CLA-1816 strongly binds with and activates the alpha3 glycine pain receptor in the spine. The Company has leased a laboratory, office, and archival space in Beverly, Massachusetts.


TSXV:CLAS.H - Post by User

Comment by Amazighon Jun 13, 2021 5:07pm
253 Views
Post# 33379704

RE:Vote No to Reverse Split

RE:Vote No to Reverse Split
Hi Chritters,

I told you before and will tell you again: CLAS is not KLY anymore.
If you stay around with CLAS you will in the end earn more money than you ever earned in the past or future. But to allow this happening you should not keep prophesying and claiming reverse split results in crashes and a bad future for CLAS. I know many RS are bad, but this is not the case for CLAS. I know you voted no, that is indeed a mistake, but I would urge you to keep patience and hope others voted with their mind and not heart as the only logical thing here to do is: VOTE YES!
I mean the way you act now is like a general on retreat and before crossing the bridge to the only safe haven is blowing up that same bridge.

Use logic not feelings.

Cheers
<< Previous
Bullboard Posts
Next >>